Podcasts

FDA Approval of 177Lu-PSMA-617 for Taxane-Naive mCRPC - Oliver Sartor

PSMA DC Trial: Lutetium + SBRT to Delay ADT in Oligometastatic Prostate Cancer - Oliver Sartor

Predictive Markers in Metastatic Prostate Cancer: Insights from the VISION Trial - Oliver Sartor